NCT03979898View on ClinicalTrials.gov

Safety and Effectiveness of Autologous Adipose Tissue Derived Mesenchymal Stem Cell Implantation in Patients With CP

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

June 15, 2017

Primary Completion Date

April 23, 2019

Study Completion Date

May 13, 2019

Conditions
Cerebral Palsy
Interventions
BIOLOGICAL

ASTROSTEM

Intravenous injection of Autologous Adipose derived mesenchymal stem cells. Dose : 15kg below : 0.5x10\^7cells/5mL 15kg \~ 25kg : 1x10\^8cells/10mL 25kg over : 1.5x10\^8cells/15mL

Trial Locations (1)

Unknown

KyungHee University Gandong Hospital, Seoul

Sponsors

Lead Sponsor

R-Bio
All Listed Sponsors
collaborator

Kyung Hee University Hospital at Gangdong

OTHER

lead

R-Bio

INDUSTRY

NCT03979898 - Safety and Effectiveness of Autologous Adipose Tissue Derived Mesenchymal Stem Cell Implantation in Patients With CP | Biotech Hunter | Biotech Hunter